US Stock MarketDetailed Quotes

TEVA Teva Pharmaceutical Industries

Watchlist
  • 17.220
  • -0.150-0.86%
Trading Nov 12 14:44 ET
19.51BMarket Cap-20258P/E (TTM)

Teva Pharmaceutical Industries Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Teva Pharmaceutical Industries Q3 2024 Earnings Date

Currency：USDNov 6, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
4.13B
4.33B
+206.96M
Beat Est.
+7.14%
+12.52%
+5.02%
EPS
-<0.01
-0.39
-0.39
Miss Est.
-103.57%
-750.00%
-15500.00%
Analyst Rating
Strong Buy

Nov 11, 2024

Teva Pharmaceutical Industries Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
Date Period Revenue/Estimate Earnings Call
-- 2025/Q1 -- / 3.829B --
-- 2024/Q4 -- / 4.091B --
Nov 6, 2024 2024/Q3 4.332B / 4.125B --
Jul 31, 2024 2024/Q2 4.164B / 4.045B --
May 8, 2024 2024/Q1 3.819B / 3.740B --
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 3.829B--
--2024/Q4-- / 4.091B--
Nov 6, 20242024/Q34.332B / 4.125B--
Jul 31, 20242024/Q24.164B / 4.045B--
May 8, 20242024/Q13.819B / 3.740B--

Unlock Free Earnings Estimates

Teva Pharmaceutical Industries Earnings Reports

  • 10-Q: Q3 2024 Earnings Report

    Nov 7 05:15

  • 10-Q: Q2 2024 Earnings Report

    Aug 1 04:11

  • 10-Q: Q1 2024 Earnings Report

    May 9 05:14

  • Teva Pharmaceutical Industries | 10-K: FY2023 Annual Report

    Feb 12 20:09

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 11, 2024

    Strong Buy

    • Buy

      83.33%

    • Hold

      16.67%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data

    Concept Cannabis & Hemp
    Cannabis & Hemp
    Intraday-0.24%
    Infectious Disease
    Infectious Disease
    Intraday-0.65%